Canal Insurance Company’s Exelixis EXEL Stock Holding History

Canal Insurance Company’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Hold	20,000	–	–	0.24%	61
2026 Q1	$858K	Buy	+20,000	New	+$860K	0.18%	64

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canal Insurance Company's EXEL Position: Q2 2026 in Review

Canal Insurance Company held its Exelixis (EXEL) position steady in Q2 2026 at 20,000 shares worth $1.09M. The position accounts for 0.24% of the portfolio, ranked #61.

Canal Insurance Company first reported a position in EXEL in Q1 2026 and has held it in 2 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

Canal Insurance Company held 20,000 shares of Exelixis worth $1.09M as of Q2 2026.
Canal Insurance Company left its Exelixis share count unchanged in Q2 2026.
Exelixis made up 0.24% of Canal Insurance Company's portfolio in Q2 2026, its #61 holding.
Canal Insurance Company first reported a position in Exelixis in Q1 2026 and has held it in 2 quarters since.
760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Canal Insurance Company's 13F filing for Q2 2026, filed 21 Jul 2026.